Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Basalioma]

E Diem1

  • 1Klinik für Dermatologie, Abteilung für Allgemeine Dermatologie I, Universität Wien.

Therapeutische Umschau. Revue Therapeutique
|December 1, 1993
PubMed
Summary
This summary is machine-generated.

Basal cell carcinoma (BCC) treatment aims for complete tumor destruction, considering tumor type and location. Microscopic control after excision prevents recurrence, especially for facial BCC.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-return valves do not prevent backflow and bacterial contamination of intravenous infusions.

The Journal of hospital infection·2011
Same author

About the clinical importance of capillary resistance.

Cardiologia·2010
Same author

Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2007
Same author

Expression of RPE65, a putative receptor for plasma retinol-binding protein, in nonmelanocytic skin tumours.

The British journal of dermatology·2005
Same author

Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.

British journal of cancer·2005
Same author

Looking beyond caseload numbers for long-term home-care case managers.

Care management journals : Journal of case management ; The journal of long term home health care·2002
Same journal

[Multimodal Cardiac Imaging: New Developments for Clinical Practice].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Coronary angiography: From cardiac catheterization to advanced interventional cardiovascular imaging].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Athlete's heart: role of cardiac imaging in the prevention of sudden cardiac death].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Multimodal imaging in cardiac amyloidosis and cardiac sarcoidosis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Inflammatory Heart Disease: The Role of Multimodality Cardiac Imaging in Myocarditis and Pericarditis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

State-of-the-Art Cardiac Imaging

Therapeutische Umschau. Revue therapeutique·2026
See all related articles

Area of Science:

  • Dermatology
  • Oncology

Context:

  • Basal cell carcinoma (BCC) is a common skin cancer.
  • Therapeutic strategies must address BCC's biological and histological characteristics.
  • Critical anatomical sites necessitate precise treatment protocols.

Purpose:

  • To outline effective treatment strategies for basal cell carcinoma (BCC).
  • To emphasize the importance of microscopic control in preventing BCC recurrence.
  • To highlight the individualized approach based on BCC type, location, and patient age.

Summary:

  • Complete destruction of basal cell carcinoma (BCC) is the primary therapeutic goal.
  • Treatment selection depends on BCC's biological type, histological form, and patient factors.
  • Microscopic examination post-excision is crucial for preventing destructive recurrence, particularly in critical facial areas.

Related Experiment Videos

Impact:

  • Improved patient outcomes through tailored and effective BCC management.
  • Reduced risk of disfigurement and functional impairment from recurrent BCC.
  • Enhanced understanding of BCC treatment nuances for dermatologists and oncologists.